Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Atacand to be divested to Cheplapharm in Europe
-
Lynparza approved in Japan for BRCA-mutated metastatic breast cancer
-
Imfinzi approved in Japan for unresectable Stage III non-small cell lung cancer
-
Bydureon receives positive EU CHMP opinion for new BCise device for patients with type-2 diabetes
-
Lynparza significantly delays disease progression in Phase III 1st-line SOLO-1 trial for ovarian cancer
-
AstraZeneca to share latest data from an industry-leading portfolio that aims to advance clinical understanding of diabetes and CV risk management at ADA 2018
-
Update on Phase III clinical trials of lanabecestat for Alzheimer’s disease
-
The EU approves Tagrisso for 1st-line treatment of EGFR-mutated non-small cell lung cancer
-
Lynparza in combination with abiraterone delayed disease progression in metastatic castration-resistant prostate cancer
-
Moxetumomab pasudotox pivotal data in patients with previously-treated hairy cell leukaemia presented at the 2018 ASCO Annual Meeting
Latest articles and press releases
All of our latest press releases and articles are available to explore
